Dr. Matthew Hamill is interested in all aspects of Sexually Transmitted Infections (STI) and HIV. This includes, prevention, treatment, and retention in care. His research focuses on rapid, Point-of-Care diagnostics for STI in low-income settings. He provides patient-focused treatment for those with, or at risk of, STI and HIV (including Pre Exposure Prophylaxis/PrEP). He has expertise in providing care for LGBTQ+ communities. Dr. Hamill is a UK-trained physician, he received his medical degree in 1998 (MB ChB), trained in internal medicine followed by sexual health/HIV training in London, UK. He spent 3 years conducting research in Soweto, South Africa. In addition to his primary affiliation with Johns Hopkins School of Medicine, he is also affiliated with the Department of Population, Family, and Reproductive Health at the Bloomberg School of Public Health. Dr. Hamill is rated as a Distinguished provider by MediFind in the treatment of Syphilis. His top areas of expertise are Syphilis, Gonorrhea, Urethritis, and Neurosyphilis.

Dr. Yukari Manabe is a Professor in the Division of Infectious Diseases in the Department of Medicine with secondary appointments in the Bloomberg School of Public Health Department of International Health and the Department of Microbiology and Molecular Immunology. Dr. Manabe began her career working on the basic science aspects of tuberculosis (TB) immunopathogenesis in comparative animal models of infection, particularly latency, reactivation, and immune reconstitution inflammatory syndrome (IRIS) in the rabbit model within the Johns Hopkins Center for Tuberculosis Research. In 2007, she was seconded to the Infectious Diseases Institute (IDI) at Makerere College of Health Sciences as the Associate Medical Laboratory Director of the College of American Pathologists certified Makerere University-Johns Hopkins University Clinical Core Lab to study antiretroviral associated TB and IRIS. She then became the Head of Research at the IDI in 2008 until 2012 where she built research capacity and infrastructure to train Ugandan investigators. Since returning to Hopkins, she has become the PI of the Johns Hopkins POC STD Center (U54 funded through NIH) which is part of the newly formed Johns Hopkins Center for Innovative Diagnostics for Infectious Diseases. The Center develops new diagnostics, funds development for point-of-care diagnostics, evaluates (validation and verification) new technology, and performs pre-clinical studies to accelerate the development of infectious disease assays (STIs, TB, acute febrile illness, HIV, syphilis, viral hepatitis). Dr. Manabe is particularly interested in rapid, point-of-care infectious disease diagnostics suitable for the resource-limited settings particularly in sub-Saharan Africa (SSA). Her research has focused on accuracy testing of various rapid, point-of-care diagnostics for HIV and related infectious diseases of clinical importance in SSA. Studies have ranged from evaluations of performance accuracy through clinical implementation science studies on the patient-centered outcomes and impactful use of new rapid diagnostics. Dr. Manabe obtained her undergraduate degree from Yale University and her M.D. from Columbia University College of Physicians and Surgeons. After completing both her residency in Internal Medicine and fellowship in Infectious Diseases at Johns Hopkins Hospital, she joined the faculty in 1999. Dr. Manabe is rated as a Distinguished provider by MediFind in the treatment of Syphilis. Her top areas of expertise are HIV/AIDS, Cryptococcosis, Gonorrhea, Meningitis, and Tissue Biopsy.

Dr. Susan Tuddenham is an associate professor of medicine at the Johns Hopkins University School of Medicine. She received her M.P.H. from the Johns Hopkins Bloomberg School of Public Health and her M.D. from the David Geffen School of Medicine at UCLA. She completed her residency in internal medicine and her fellowship in infectious diseases at the Johns Hopkins Hospital. Her research interests are in sexually transmitted infections, HIV, and the human microbiome in the context of infectious diseases. Her outpatient clinical practice focuses on recurrent vaginitis (including Bacterial Vaginosis and Vulvovaginal Candidiasis), Sexually Transmitted Infections, and recurrent Urinary Tract Infections in women. Dr. Tuddenham is rated as a Distinguished provider by MediFind in the treatment of Syphilis. Her top areas of expertise are Neurosyphilis, Syphilis, Gonorrhea, and Vaginal Yeast Infection.

Khalil Ghanem's, M.D., Ph.D., research interests include sexually transmitted infections and the vaginal microbiome. In 2008, he received his Ph.D. degree in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health. Dr. Ghanem is rated as a Distinguished provider by MediFind in the treatment of Syphilis. His top areas of expertise are Neurosyphilis, Syphilis, Gonorrhea, and Chlamydia.

Dr. Thomas Quinn is professor of medicine and pathology in the Johns Hopkins School of Medicine and professor of international health, epidemiology, and molecular microbiology and immunology in The Johns Hopkins School of Public Health, and professor of nursing in the Johns Hopkins School of Nursing. In 2006 he was appointed founding Director of the Johns Hopkins University Center for Global Health. He serves as advisor/consultant on HIV and STDs to the World Health Organization, Office of the Global AIDS Coordinator (PEPFAR), UNAIDS, and the FDA. He serves as Associate Director for International Research at the National Institute of Allergy and Infectious Diseases. He is a member of the Institute of Medicine of the National Academy of Sciences, and is a fellow of the American Association for the Advancement of Science. He is a fellow of the Infectious Diseases Society of America and a member of the American Association of Physicians. He is an author of over 900 publications on HIV, STDs, and infectious diseases, and serves on multiple editorial boards. Among his professional activities, Dr. Quinn is an alternate member of the Technical Panel of the Global Fund to Fight AIDS, Malaria, and Tuberculosis and has been on Advisor/Consultant on HIV and STDs to the World Health Organization, UNAIDS, and the U.S. Food and Drug Administration. In October 2004 he received membership in the Institute of Medicine. Dr. Quinn is rated as an Advanced provider by MediFind in the treatment of Syphilis. His top areas of expertise are HIV/AIDS, Genital Herpes, Chlamydia, and Human Papillomavirus Infection.

Dr. Allison L. Agwu, MD, ScM, FAAP, FIDSA is Professor of pediatric and adult infectious diseases at the Johns Hopkins University School of Medicine. Her clinical interests include HIV/AIDS and infectious disease. Dr. Agwu earned her medical degree from the University of Maryland School of Medicine. She completed a residency in pediatrics and internal medicine at Case Western Reserve University (University Hospitals of Cleveland/ Rainbow Babies and Children’s Hospital), and a combined fellowship in pediatric and adult infectious diseases at the Johns Hopkins School of Medicine. Dr. Agwu's clinical and research interests focuses on children, adolescents, and young adults who are at-risk or living with HIV and their families. Clinically, she provides inpatient and outpatient pediatric infectious diseases' consultations and leads the Pediatric Adolescent HIV/AIDS Program, which provides multidisciplinary for those living with or affected by HIV. Further, she leads the young adult transition clinic, the Accessing Care Early (ACE) Clinic. Both programs are longstanding Ryan White Federal Grant-funded programs. Her overarching research goal is to decipher, address, and minimize disparities in treatment and outcomes for those living with HIV. Toward this goal, she oversees her own independent, longstanding, federally funded clinical research program and serves as principal investigator of the Johns Hopkins sites of the International Maternal, Pediatric, and Adolescent AIDS Clinical Trials (IMPAACT) Network and the Adolescent Trials' Network (ATN). Her research interests include optimizing outcomes for youth at-risk for and living with HIV, management and treatment strategies, and minimizing disparities in the use of antiretroviral therapy (ART) and outcomes. Other special interests include epidemiologic approaches to HIV, drug resistance, and clinical trials. She is a member of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. Dr. Agwu is Chair of the HIV Medicine Association. Dr. Agwu is rated as an Experienced provider by MediFind in the treatment of Syphilis. Her top areas of expertise are HIV/AIDS, Gonorrhea, Chlamydia, and COVID-19.

Dr. Joyce Leitch Jones is a faculty member at the Johns Hopkins University School of Medicine. Her area of clinical expertise is infectious diseases. Dr. Jones earned her M.D. at the University of Maryland School of Medicine. She completed her residency at Columbia University Medical Center and performed a fellowship in epidemiology at Weill Cornell Medical College. Dr. Jones is rated as an Experienced provider by MediFind in the treatment of Syphilis. Her top areas of expertise are HIV/AIDS, Myelitis, AIDS Dementia Complex, and AIDS Dysmorphic Syndrome.

Dr. Gail Berkenblit is an assistant professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include infectious disease and internal medicine. Dr. Berkenblit serves as the associate program director for ambulatory education of the Osler Medicine Housestaff Training Program. She received her undergraduate degree from MIT in 1990. She began her medical training in the Health Sciences and Technology joint program between Harvard and MIT. She completed her Ph.D. in the division of cell and developmental biology at Harvard, discovering the role of homeobox genes in uterine development and embryo implantation. She completed medical school and residency training in internal medicine at Johns Hopkins. Her research interests include the design and evaluation of an internet-based curriculum and improving resident training in HIV outpatient care. Dr. Berkenblit serves as chair of the Society of General Internal Medicine’s AIDS Task Force. She was recognized with the David E. Rogers Junior Faculty Education Award by the Society of General Internal Medicine in 2011. Dr. Berkenblit is rated as an Experienced provider by MediFind in the treatment of Syphilis. Her top areas of expertise are Hepatitis C, Hepatitis, HIV/AIDS, and Myelitis.

Meghan Berkenstock, M.D., is an associate professor of ophthalmology at the Johns Hopkins Wilmer Eye Institute. She specializes in ocular inflammatory and infectious diseases, cataract surgery, and comprehensive ophthalmology. Since joining the faculty of the Wilmer Eye Institute in 2016, she has established a research focus on risk reduction and quality assurance initiatives in the care of patients with uveitis. She has implemented several initiatives to improve laboratory monitoring and understanding barriers to care in patients on immunosuppressive medications. The bulk of her research focuses on identifying ocular adverse events (IRAE) associated with the use of immunotherapy agents in the treatment of systemic malignancies. She is a member and the only ophthalmologist on the National Comprehensive Cancer Network Panel on developing guidelines to treat IRAEs. Dr. Berkenstock is rated as an Experienced provider by MediFind in the treatment of Syphilis. Her top areas of expertise are Scleritis, Episcleritis, Uveitis, Vitrectomy, and Cataract Removal.

Dr. Kathleen Page is a Professor of Medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include infectious diseases, HIV/AIDS, substance use disorder. She received her undergraduate degree in public health from Johns Hopkins and earned her M.D. from Washington University School of Medicine. She completed her residency at the Hospital of the University of Pennsylvania and performed a fellowship in infectious diseases at Johns Hopkins. Dr. Page joined the Johns Hopkins faculty in 2006. Dr. Page is dedicated to improving access to high-quality care for underserved communities, including people living with HIV, migrants, and individuals with substance use disorders. Her research spans migrant health, infectious diseases, health and human rights, mobile health interventions, and implementation science. As the principal investigator on multiple grants, she leads studies on integrated care models for behavioral health, mHealth tools for HIV care, and strategies to increase equitable access to evidence-based health interventions. Dr. Page is Co-Director of the Center for Community and Global Health in Infectious Diseases (CCGHE-ID) whose mission is to improve health and equity, locally and abroad, through infectious diseases scientific research, training, advocacy, and service. Dr. Page is rated as an Experienced provider by MediFind in the treatment of Syphilis. Her top areas of expertise are HIV/AIDS, COVID-19, Severe Acute Respiratory Syndrome (SARS), and Hepatitis C.

Dr. Kelly Gebo is a graduate of The Johns Hopkins University School of Medicine. She also earned an MPH in Epidemiology from The Johns Hopkins Bloomberg School of Public Health. She completed residency training in Internal Medicine at The Johns Hopkins Hospital followed by an infectious diseases fellowship and two additional years of fellowship training as a Robert Wood Johnson Clinical Scholar, also at Hopkins. Her clinical and research interests include clinical outcomes and healthcare utilization research within infectious diseases. She was Director of the JHU Public Health Studies Program between the Krieger School for Arts and Sciences and the Bloomberg School for Public Health, was an American Council of Education Fellow (hosted at the University of Pennsylvania) and was the inaugural Vice Provost for Education at Johns Hopkins. She was on sabbatical at Stanford University School of Medicine 2019-20 and served as the Chief Medical and Scientific Officer for the All of Us Research Program 2018-2020. She currently serves as the director of the Johns Hopkins Clinical Research Scholars Program and is Deputy Director of the Johns Hopkins Institute for Clinical and Translational Research. She has mentored undergraduate, public health and medical students, trainees, and junior faculty on infectious diseases and health services projects. She has authored or co-authored numerous chapters and over 250 papers. She is a member of the American Society of Clinical Investigation and has been awarded the David Levine Prize for mentoring at Johns Hopkins. LinkedIn https://www.linkedin.com/in/kelly-gebo-13377811/. Dr. Gebo is rated as an Experienced provider by MediFind in the treatment of Syphilis. Her top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex.

Dr. Joel Blankson is an associate professor of medicine at the Johns Hopkins University School of Medicine. He also holds an appointment in molecular and comparative pathobiology. His areas of clinical expertise include HIV pathogenesis and infectious disease. Dr. Blankson earned his M.D. from Cornell University Medical College and his Ph.D. from Rockefeller University. He completed his residency and a fellowship in infectious disease at Johns Hopkins. His research interests include the natural control of HIV-1 infection. Dr. Blankson is rated as an Experienced provider by MediFind in the treatment of Syphilis. His top areas of expertise are HIV/AIDS, Myelitis, AIDS Dementia Complex, and AIDS Dysmorphic Syndrome.

Dr. William Garneau is a native of Durham, North Carolina. He graduated from Yale University with a degree in English and served as a middle school teacher in the Peace Corps in Namibia. He is a graduate of the University of North Carolina School of Medicine and earned a Master of Public Health at the UNC Gillings School of Global Public Health. He completed internal medicine residency training at the Johns Hopkins Hospital and is an assistant professor of medicine in the Division of Hospital Medicine. In 2023 he received a KL2 mentored Career Development award from the National Institutes of Health. He is currently enrolled in the Graduate Training Program in Clinical Investigation at the Johns Hopkins Bloomberg School of Public Health. Dr. Garneau's research uses observational data to study health outcomes including novel therapies and emerging illnesses. His prior research includes studies of mpox and COVID-19. He additionally serves as a lead informaticist with the Critical Path Institute's CURE ID project. His clinical responsibilities include providing direct care to hospitalized patients, serving as a medicine consultant to surgical services, and attending on resident teaching teams. In addition to his clinical work, Dr. Garneau is a Barker Firm Faculty member and teaches students in the Johns Hopkins School of Medicine as well as the Osler Medical Residency Training Program. Dr. Garneau is rated as an Experienced provider by MediFind in the treatment of Syphilis. His top areas of expertise are Monkeypox, Severe Acute Respiratory Syndrome (SARS), COVID-19, and Syphilis.

Dr. Petros Karakousis is a Professor of Medicine at the Johns Hopkins University School of Medicine. He has joint appointments in Molecular Microbiology & Immunology and International Health at the Johns Hopkins Bloomberg School of Public Health. His areas of clinical expertise include infectious diseases and tuberculosis. Dr. Karakousis received his undergraduate degree in 1994 from the Johns Hopkins University and his medical degree in 1998 from Washington University School of Medicine in St. Louis. He completed residency training in internal medicine in 2001 at the Hospital of the University of Pennsylvania. After completing fellowship training in infectious diseases at Johns Hopkins, he joined the Department of Medicine faculty in 2005. His research interests include tuberculosis pathogenesis, Mycobacterium tuberculosis persistence and antibiotic tolerance, host-pathogen interactions and host-directed therapies. Dr. Karakousis was named a Fellow of the Infectious Diseases Society of America in 2010, and was elected to the American Society for Clinical Investigation in 2021. He has held numerous leadership positions, including in the Working Group on New TB Drugs of the Stop TB Partnership. He has served on the editorial board of various scientific journals and on numerous NIH study sections, and as a peer reviewer for many international government and private funding agencies. Dr. Karakousis is rated as an Experienced provider by MediFind in the treatment of Syphilis. His top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex.

Anne Rompalo is an Infectious Disease provider in Baltimore, Maryland. Dr. Rompalo is rated as a Distinguished provider by MediFind in the treatment of Syphilis. Her top areas of expertise are Syphilis, Gonorrhea, Trichomoniasis, and Genital Herpes.

Dr. Trevor Crowell is an adjunct assistant professor at the Johns Hopkins University School of Medicine. His areas of clinical expertise include HIV/AIDS, sexually transmitted infections, and other infectious diseases. Dr. Crowell earned his M.D. from the University of Southern California Keck School of Medicine and his Ph.D. in clinical investigation from the Johns Hopkins Bloomberg School of Public Health. He completed his residency at Case Western Reserve University/University Hospitals Case Medical Center and completed a fellowship in infectious diseases at Johns Hopkins. In addition to serving as a staff physician at Bayview Medical Center, Dr. Crowell is an Associate Director at the U.S. Military HIV Research Program, Walter Reed Army Institute of Research. He is also an assistant professor of medicine at the Uniformed Services University of the Health Sciences. Dr. Crowell is rated as an Experienced provider by MediFind in the treatment of Syphilis. His top areas of expertise are HIV/AIDS, Gonorrhea, Sepsis, and Chlamydia.

Zach Lorenz is a primary care provider, practicing in Internal Medicine in Baltimore, Maryland. Dr. Lorenz is rated as an Experienced provider by MediFind in the treatment of Syphilis. His top areas of expertise are Syphilis and Neurosyphilis.

Dr. Rachel M. Kruzan is an instructor of medicine at the Johns Hopkins University School of Medicine. Her area of clinical expertise is internal medicine. Dr. Kruzan earned her M.D. from Rush Medical College. She completed her residency at Johns Hopkins Bayview Medical Center. She has been recognized by the Johns Hopkins Institutions Diversity Leadership Council with a Diversity Recognition Award. Dr. Kruzan is rated as an Experienced provider by MediFind in the treatment of Syphilis. Her top areas of expertise are Diabetic Neuropathy, Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), and Familial Hypertension.

Sebastian Ruhs is an Infectious Disease provider in Baltimore, Maryland. Dr. Ruhs is rated as an Advanced provider by MediFind in the treatment of Syphilis. His top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex. Dr. Ruhs is currently accepting new patients.

Dani Boulattouf is a primary care provider, practicing in Family Medicine in Baltimore, Maryland. Dr. Boulattouf is rated as an Advanced provider by MediFind in the treatment of Syphilis. His top areas of expertise are Acute Cystitis, Bronchitis, Flu, and Parainfluenza.